Form 4 for GOSS Gossamer Bio, Inc.
Accepted 2023-11-14 00:00:00 ET · period of report 2023-11-13 · accession 0001728117-23-000136 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2023-11-14 | 2023-11-13 | GOSS | Giraudo Bryan | COO, CFO | P - Purchase | $0.56 | +200.0K | 380.0K | +111% | +$112.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-11-13 | P | A | 200,000 | $0.56 | 380,010 | I By family trust | — | — | (F1) This transaction was executed in multiple trades at prices ranging from $0.5557 to $0.5723 per share. The price reported above reflects the weighted average sale price for the entire number of shares sold. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request. |